At 16.5% CAGR, the Europe Disposable Endoscope Market is projected to be worth US$ 770.99 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Europe disposable endoscope market was valued at US$ 309.07 million in 2022 and is expected to reach US$ 770.99 million by 2028, registering a CAGR of 16.5% from 2022 to 2028. Rising incidence of hospital-acquired infections (HAI) due to contaminated endoscopes and increased focus on patient safety and workflow efficiency are the critical factors attributed to the Europe disposable endoscope market expansion.             

In recent years, there has been a growing awareness about the risk of cross-contamination due to reusable endoscopes which can carry harmful organisms among patients. With regard to reusable endoscopy, FDA has intensified its guidelines by issuing safety communications and highlighting risks across pulmonology, urology, ENT, and gastroenterology. Furthermore, over the past few years, there has been an increase in reusable endoscope recalls and safety warnings related to endoscope use in the urology, ENT, and gastroenterology branches. The Association for the Advancement of Medical Instrumentation (AAMI) has classified pulmonology, urology, and GI endoscopes as high-risk and has put in place highly stringent cleaning guidelines, which has increased the cost and the complexity of reusable endoscopy.

Reusable endoscope in the hospital systems requires complex reprocessing equipment, including drying equipment, and trained staff. Further, reprocessing delays, equipment downtime, endoscope breaks, and staff shortages can result in procedure delays and other inefficiencies, which can negatively impact patient care. However, single-use endoscopes are sterile and easily available.

They do not require complex reprocessing infrastructure reduces both labor and capital intensity whereas reusable endoscopes are both capital- and labor-intensive. Demand for single-use endoscopes continues to grow rapidly as healthcare professionals seek high-performing and intuitive endoscopy solutions that enhance patient safety, provide tangible workflow and efficiency benefits, and incorporate the latest technology advances.

Thus, due to an increasing focus on patient safety and workflow efficiency, the Europe disposable endoscope market is growing at a rapid pace. This is expected to drive the Europe disposable endoscope market during the forecast period.

On the contrary, accumulation of medical waste due to disposable endoscopes hurdles the growth of Europe disposable endoscope market. 

Based on application, the Europe disposable endoscope market is categorized into GI endoscopy, bronchoscopy, urologic endoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held 33.9% share of Europe disposable endoscope market in 2022, amassing US$ 104.90 million. It is projected to garner US$ 257.94 million by 2028 to expand at 16.2% CAGR during 2022–2028.

Based on end user, the Europe disposable endoscope market is categorized into hospitals, diagnostic centers, and clinics. The hospitals segment held 50.3% share of Europe disposable endoscope market in 2022, amassing US$ 155.56 million. It is projected to garner US$ 396.76 million by 2028 to expand at 16.9% CAGR during 2022–2028.

Based on country, the Europe disposable endoscope market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 31.2% share of Europe disposable endoscope market in 2022. It was assessed at US$ 96.43 million in 2022 and is likely to hit US$ 250.96 million by 2028, exhibiting a CAGR of 17.3% during the forecast period.            

Key players dominating the Europe disposable endoscope market are Boston Scientific Corp; Ambu AS; Consis Medical Ltd; Hill-Rom Services Inc.; Karl Storz SE & Co KG; Flexicare (Group) Ltd; OBP Medical Corp; Parburch Medical Developments Ltd; and Coloplast Corp among others.

• In Jan 2022, Flexicare and TSC Endovision announce distribution partnership
• In Nov 2021, Coloplast acquires laryngectomy device maker Atos Medical in $2.5B takeover.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com